Related Experiment Video

Updated: Jul 16, 2026

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Clinical experience with gene therapy for the treatment of prostate cancer

Matthew A Stanizzi1, Simon J Hall

  • 1Department of Urology, The Barbara and Maurice A. Deane Prostate Health and Research Center, Mount Sinai School of Medicine New York, NY.

Reviews in Urology
|March 28, 2007
PubMed

Insights

New prostate cancer treatments are needed, especially for advanced stages. Gene therapy offers promising strategies, including direct tumor injection and systemic delivery, to combat prostate cancer and its metastases effectively.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Localized prostate cancer is treatable with surgery or radiation.
  • Metastatic prostate cancer options are limited to hormonal therapy.
  • Hormone-refractory prostate cancer has a modest survival benefit with chemotherapy, necessitating novel treatments.

Purpose of the Study:

  • To review various cancer gene therapy strategies for prostate cancer.
  • To focus on gene therapy approaches that have entered clinical trials.
  • To detail clinical experiences with gene therapy in prostate cancer patients.

Main Methods:

  • Overview of gene therapy strategies for prostate cancer.
  • Focus on clinical trial data.
  • Review of clinical outcomes in prostate cancer patients undergoing gene therapy.

Main Results:

  • Gene therapy strategies include direct tumor injection, systemic delivery for metastases, and local expression for systemic response.
  • Several gene therapy approaches have progressed to clinical trials for prostate cancer.
  • Clinical experience provides insights into the efficacy and safety of these novel treatments.

Conclusions:

  • Gene therapy represents a promising avenue for treating prostate cancer, particularly advanced and refractory forms.
  • Clinical trials are crucial for evaluating the effectiveness of different gene therapy modalities.
  • Further research and development in gene therapy are essential for improving patient outcomes in prostate cancer.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...